Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Roche confirms 2020 outlook as Covid-19 diagnostics surge

Ruchika Sharma16 Oct 2020 9:00 AM IST

Zurich: The frantic global effort to test people for Covid-19 pushed Roche's diagnostics division to record revenue, helping the Swiss drugmaker...

Dr Reddys submits revised protocol to DCGI for Sputnik V phase 2,3 trials

Ruchika Sharma15 Oct 2020 12:45 PM IST

Recently, the expert panel of DCGI had recommended that Dr Reddy's Lab submit a fresh application to the top drug regulator seeking its consideration.

SPARC investigational drug shows promise in phase 3 trial for treating inflammation, pain related to ocular surgery

Ruchika Sharma15 Oct 2020 12:30 PM IST

The objective of the trial was to assess the efficacy and safety of SDN-037 in clearing the inflammation and pain, the company added.

Abbott launches heart rhythm management devices ICD, CRT-D in India

Ruchika Sharma15 Oct 2020 12:00 PM IST

The devices offer new opportunities for patient engagement and remote monitoring through smartphone connectivity and connected applications, it added.

Hindustan Syringes and Medical Devices sends 56 million auto-disable syringes shipment to Covax facility

Ruchika Sharma15 Oct 2020 11:00 AM IST

New Delhi: Hindustan Syringes & Medical Devices on Wednesday said it has sent the first shipment of 56 million auto-disable syringes to Covax...

Pfizer, BioNTech ink deal with New Zealand for COVID-19 vaccine

Ruchika Sharma15 Oct 2020 9:00 AM IST

Sydney: The New Zealand government signed a deal on Monday to buy 1.5 million COVID-19 vaccines from Pfizer Inc and Germany's BioNTech, with delivery...

Setback: Eli Lilly halts Covid vaccine trial over safety concerns

Ruchika Sharma14 Oct 2020 3:15 PM IST

"Eli Lilly is supportive of the decision by the independent (Data Safety Monitoring Board) to cautiously ensure the safety of patients participating...

Glenmark launches pulmonary fibrosis drug NINDANIB in India

Ruchika Sharma14 Oct 2020 1:00 PM IST

Nintedanib is approved by the Indian drug regulator for the treatment of Idiopathic (unknown cause) Pulmonary Fibrosis (IPF).

COVID-19: Govt ponders strategy for vaccine availability, distribution by July 2021

Ruchika Sharma14 Oct 2020 12:31 PM IST

"For this, strategies that have been adopted by the world be it CDC, US are being studied continuously. Digital platforms are also being prepared for...

Alembic Pharma Secures USFDA Tentative Approval for Bosulif Generic Bosutinib 400 mg

Alembic Pharma arm, Curon join hands for cancer drug Tenalisib in Greater China

Ruchika Sharma14 Oct 2020 12:00 PM IST

Alembic Pharma said Curon obtains the exclusive development and commercialisation rights of Tenalisib for Greater China across all oncology...

Bangladesh declines to approve Chinese COVID vaccine trial by Sinovac Biotech

Ruchika Sharma14 Oct 2020 11:26 AM IST

Sinovac Biotech Ltd in a letter on September 24 said the trial would be delayed unless the government provided funds, although the company was...

Covid-19: Daewoong Pharma gets regulatory okay for phase 1 trial of anti-parasitic niclosamide drug

Ruchika Sharma13 Oct 2020 3:00 PM IST

Daewoong had said its anti-viral drug had completely eliminated the novel coronavirus from animals' lungs during pre-clinical testing.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok